Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma. | Cancer Res | 2022 | 36219398 | PubTator, text mining | PubMed |
| Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index. | J Oncol | 2022 | 36213825 | PubTator, text mining | PubMed |
Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision. | Cancer Manag Res | 2022 | 36200095 | PubTator, text mining | PubMed |
| Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. | Mol Diagn Ther | 2022 | 36178671 | PubTator, text mining | PubMed |
| Dynamic Modelling of DNA Repair Pathway at the Molecular Level: A New Perspective. | Front Mol Biosci | 2022 | 36177351 | PubTator, text mining | PubMed |
| Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer. | World J Gastroenterol | 2022 | 36157935 | PubTator, text mining | PubMed |
| Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer. | Cancers (Basel) | 2022 | 36139600 | PubTator, text mining | PubMed |
| Deletion of mdig enhances H3K36me3 and metastatic potential of the triple negative breast cancer cells. | iScience | 2022 | 36124233 | PubTator, text mining | PubMed |
| Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication. | EBioMedicine | 2022 | 36116213 | PubTator, text mining | PubMed |
| DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination. | Front Oncol | 2022 | 36110934 | PubTator, text mining | PubMed |
| Homologous recombination-deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants. | Proc Natl Acad Sci U S A | 2022 | 36099300 | PubTator, text mining | PubMed |
| A PARP1-related prognostic signature constructing and PARP-1 inhibitors screening for glioma. | Front Cell Dev Biol | 2022 | 36092717 | PubTator, text mining | PubMed |
| Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability. | Front Oncol | 2022 | 36091172 | PubTator, text mining | PubMed |
| A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer. | Front Immunol | 2022 | 36081518 | PubTator, text mining | PubMed |
| BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside. | Cancers (Basel) | 2022 | 36010882 | PubTator, text mining | PubMed |
| Understanding Role of DNA Repair and Cytochrome p-450 Gene Polymorphisms in Cervical Cancer Patient Treated With Concomitant Chemoradiation. | Br J Biomed Sci | 2022 | 35996502 | PubTator, text mining | PubMed |
| Impact of homologous recombination deficiency biomarkers on outcomes in patients with early breast cancer: a systematic review protocol. | BMJ Open | 2022 | 35981778 | PubTator, text mining | PubMed |
| Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis. | Biomed Res Int | 2022 | 35978646 | PubTator, text mining | PubMed |
| Novel neoplasms associated with syndromic pediatric medulloblastoma: integrated pathway delineation for personalized therapy. | Cell Commun Signal | 2022 | 35978432 | PubTator, text mining | PubMed |
| Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults. | Leukemia | 2022 | 35974102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=15